Stocktoria

XBiotech Inc. XBIT

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2015-04-15 · LEI

XBiotech Inc. statistics & valuation

P / B0.5×
Return on capital-39.2%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
21.50% 68.40% 83.80% 2016201720182019202020212022202320242025
Operating margin (%)
-41.50% -136.40% -860.10% 2016201720182019202020212022202320242025
Return on equity (%)
-89.30% -55.10% -51.10% 88.50% -3.20% -6.50% -13.70% -11.20% -21.10% -32.40% 2016201720182019202020212022202320242025
Shares outstanding
32.6M 35.4M 35.9M 46.3M 30.8M 30.4M 30.4M 30.4M 30.5M 30.5M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-78.70% -52.60% -47.70% 81.90% -3.20% -6.30% -13.40% -10.80% -19.40% -30.30% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-156.50% 358.40% -384.30% 2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
-$0.95 -$0.59 $14.44 -$0.36 -$0.58 -$1.08 -$0.81 -$1.26 -$1.49 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross margin83.8%68.4%21.5%
Operating margin-860.1%-136.4%-41.5%
Net margin-820.4%-94.7%-25.5%
FCF margin-384.3%358.4%-156.5%
Return on assets-30.3%-19.4%-10.8%-13.4%-6.3%-3.2%81.9%-47.7%-52.6%-78.7%
Return on equity-32.4%-21.1%-11.2%-13.7%-6.5%-3.2%88.5%-51.1%-55.1%-89.3%
Current ratio16.0111.5633.0754.0771.4981.8011.905.7811.944.64

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.